Colgate-Palmolive Company CL
Set alert
At close · Oct 30
After hours · Oct 30, 5:23 PM ET
- YTD
- +20.59%
- 1 year
- +24.55%
- Open
- 98.00
- Prev close
- 93.16
- Mkt cap
- 75.96B
- Vol
- 8.84M
- Avg vol
- 4.80M
- EPS
- 2.54
- P/E
- 37.52
- Div yield
- 2.28%
More statistics
- Low
- 94.83
- High
- 98.38
- Forward P/E
- 23.50
- Beta
- 0.32
- Short ratio
- 3.19
- Inst. own
- 86.55%
- Dividend
- 2.12
- Ex-div date
- Oct 19, 2026
- Earnings
- Jan 29, 2027
- 50-d avg
- 89.44
- 200-d avg
- 89.63
- 1y target
- 98.15
5Y chart
Events in this range
- Jan 21, 2022Dividend: 0.45
- Apr 20, 2022Dividend: 0.47
- Jul 20, 2022Dividend: 0.47
- Oct 20, 2022Dividend: 0.47
- Jan 20, 2023Dividend: 0.47
- Apr 20, 2023Dividend: 0.48
- Jul 20, 2023Dividend: 0.48
- Oct 20, 2023Dividend: 0.48
- Jan 19, 2024Dividend: 0.48
- Jan 22, 2024Dividend: 0.48
- Apr 19, 2024Dividend: 0.5
- Jul 19, 2024Dividend: 0.5
- Oct 18, 2024Dividend: 0.5
- Jan 21, 2025Dividend: 0.5
- Apr 17, 2025Dividend: 0.52
- Jul 18, 2025Dividend: 0.52
- Oct 17, 2025Dividend: 0.52
- Oct 31, 2025Earnings: 0.91; estimate 0.889; surprise 2.36%
- Jan 21, 2026Dividend: 0.52
- Jan 30, 2026Earnings: 0.95; estimate 0.912; surprise 4.17%
- Apr 20, 2026Dividend: 0.53
- May 1, 2026Earnings: 0.97; estimate 0.943; surprise 2.86%
- Jul 20, 2026Dividend: 0.53
- Jul 31, 2026Earnings: 0.99; estimate 0.947; surprise 4.54%
- Aug 3, 2026Rating: TD Cowen · Hold → Hold
- Aug 3, 2026Rating: UBS · Buy → Buy
- Sep 8, 2026Rating: RBC Capital · Outperform → Outperform
- Sep 21, 2026Rating: Piper Sandler · Overweight → Overweight
- Oct 5, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Oct 19, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 20, 2026Dividend: 0.53
- Oct 30, 2026Earnings: 0.97; estimate 0.926; surprise 4.75%
Signals (91)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| RSI: Overbought | Feb 23, 2026 | 8 months ago |
| RSI: Overbought | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 3, 2025 | 1 year ago |
| SMA: Bullish | Feb 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 23, 2024 | 2 years ago |
| SMA: Bearish | Sep 16, 2024 | 2 years ago |
| RSI: Overbought | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| RSI: Overbought | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| RSI: Overbought | Feb 19, 2024 | 2 years ago |
| RSI: Overbought | Jan 29, 2024 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| SMA: Bullish | Oct 16, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bullish | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bearish | May 29, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 3, 2023 | 3 years ago |
| SMA: Bullish | Mar 27, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 23, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Nov 21, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bearish | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bearish | May 16, 2022 | 4 years ago |
| SMA: Bullish | May 9, 2022 | 4 years ago |
| SMA: Bearish | Apr 25, 2022 | 4 years ago |
| SMA: Bullish | Apr 4, 2022 | 4 years ago |
| SMA: Bearish | Jan 31, 2022 | 4 years ago |
Key statistics
- Market cap
- 76.56B
- Enterprise value
- 81.00B
- Trailing P/E
- 37.81
- Forward P/E
- 23.50
- PEG ratio
- 1.70
- Price / sales
- 3.64
- Price / book
- 324.48
- EPS (TTM)
- 2.54
- Beta
- 0.32
- Dividend yield
- 2.28%
- Payout ratio
- 82.28%
- Profit margin
- 9.68%
- Revenue (TTM)
- 21.05B
- Revenue growth
- 4.90%
- Free cash flow
- 3.46B
- Total cash
- 1.45B
- Total debt
- 7.86B
- Return on equity
- 267.37%
- Shares outstanding
- 797.17M
- Short % of float
- 2.44%
- 50-day average
- 89.44
- 200-day average
- 89.63
Analyst view
Consensus: buy
- Target (low)
- 87.00
- Target (mean)
- 98.15
- Target (high)
- 110.00
- Strong buy6
- Buy7
- Hold7
- Sell0
- Strong sell1
Next earnings
Jan 29, 2027
Expected Jan 29, 2027. Consensus EPS estimate 0.9634.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 29, 2027 | Dec 30, 2026 | 0.97 | — | — | — |
| Oct 30, 2026 | Sep 30, 2026 | 0.926 | 0.97 | +0.04 | +4.75% |
| Jul 31, 2026 | Jun 30, 2026 | 0.947 | 0.99 | +0.04 | +4.54% |
| May 1, 2026 | Mar 31, 2026 | 0.943 | 0.97 | +0.03 | +2.86% |
| Jan 30, 2026 | Dec 31, 2025 | 0.912 | 0.95 | +0.04 | +4.17% |
| Oct 31, 2025 | Sep 30, 2025 | 0.889 | 0.91 | +0.02 | +2.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 5, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Sep 21, 2026 | Piper Sandler | main | Overweight | Overweight |
| Sep 8, 2026 | RBC Capital | reit | Outperform | Outperform |
| Aug 3, 2026 | UBS | main | Buy | Buy |
| Aug 3, 2026 | TD Cowen | main | Hold | Hold |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- colgatepalmolive.com
News
- Colgate-Palmolive vs. Lululemon Athletica: Which Consumer Goods Stock Is a Better Buy in 2026?
- Colgate-Palmolive: 3 Key Takeaways for Long-Term Investors
- Colgate-Palmolive: International Growth Push Is Working
- Colgate-Palmolive Q3 Earnings Call Highlights
- Colgate-Palmolive Q3: The Market Is Surprised When It Shouldn't Have Been
- Colgate-Palmolive Company (CL) Q3 2026 Earnings Call Transcript
- Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains
- Colgate-Palmolive (CL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
- Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs
- Colgate-Palmolive Q3 2026 Earnings Call Transcript
Your note
Sign in to keep a note on CL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BILBREY JOHN P. | Director | Stock Award(Grant) | Jun 30, 2026 | 44,948 |
| CAHILL JOHN T | Director | Conversion of Exercise of derivative security | Aug 5, 2026 | 64,730 |
| DANIELS JENNIFER M. | Officer | Stock Award(Grant) | Feb 22, 2026 | 91,681 |
| GRANT SHANE | Officer | Stock Award(Grant) | Sep 10, 2025 | 94,119 |
| HAZLIN JOHN | Officer | Stock Award(Grant) | Feb 22, 2026 | 29,874 |
| NORRINGTON LORRIE M | Director | Stock Award(Grant) | Jun 30, 2026 | 42,769 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.77% | 69,915,472 | 6.72B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.55% | 52,246,333 | 5.02B | Jun 29, 2026 |
| State Street Corporation | 5.90% | 47,020,966 | 4.52B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 3.50% | 27,909,525 | 2.68B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 3.01% | 24,021,137 | 2.31B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.90% | 23,144,319 | 2.22B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 25,400,466 | 2.44B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.60% | 20,732,788 | 1.99B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 10,622,061 | 1.02B | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 10,387,165 | 997.64M | Aug 30, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.24% | 9,863,196 | 947.31M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Value Index Fund | 0.95% | 7,610,832 | 730.98M | Jun 29, 2026 |